Interferon Tau Regulates Cytokine Production and Cellular Function in Human Trophoblast Cell Line

Journal of Interferon and Cytokine Research

Volumn 37, Issue 10, 2017, Pages 456-466

  Tanikawa, Nao ^a   Seno, Kotomi ^a   Kawahara Miki, Ryouka ^a   Kimura, Koji ^b   Matsuyama, Shuichi ^c   Iwata, Hisataka ^a   Kuwayama, Takehito ^a   Shirasuna, Koumei ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF LIVESTOCK AND GRASSLAND SCIENCE   (Japan)

Author keywords

cytokine; inflammation; interferon tau; trophoblast cells

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FLUDARABINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 7; INTERFERON REGULATORY FACTOR 9; INTERLEUKIN 6; INTERLEUKIN 8; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; PENTRAXIN 3; RETINOIC ACID INDUCIBLE PROTEIN I; STAT1 PROTEIN; STAT3 PROTEIN; TAU INTERFERON; AUTACOID; CYTOKINE; INTERFERON; ISG15 PROTEIN, HUMAN; PLACENTA PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TROPHOBLAST PROTEIN 1; UBIQUITIN;

ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MDBK CELL LINE; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REDOX STRESS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TROPHOBLAST CELL LINE; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CELL MOTION; CYTOLOGY; FEMALE; GENE EXPRESSION PROFILING; METABOLISM; OXIDATION REDUCTION REACTION; TROPHOBLAST;

CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION MEDIATORS; INTERFERON TYPE I; OXIDATION-REDUCTION; PREGNANCY PROTEINS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TROPHOBLASTS; UBIQUITINS;

EID: 85031697140     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2017.0057     Document Type: Article

References (60)

1. Alexenko AP, Ealy AD, Roberts RM. 1999. The cross-species antiviral activities of different IFN-tau subtypes on bovine, murine, and human cells: Contradictory evidence for therapeutic potential. J Interferon Cytokine Res 19(12):1335-1341.
2. Binelli M, Subramaniam P, Diaz T, Johnson GA, Hansen TR, Badinga L, Thatcher WW. 2001. Bovine interferon-tau stimulates the Janus kinase-signal transducer and activator of transcription pathway in bovine endometrial epithelial cells. Biol Reprod 64(2):654-665.
3. Brooks K, Spencer TE. 2015. Biological roles of interferon tau (IFNT) and type I IFN receptors in elongation of the ovine conceptus. Biol Reprod 92(2):47.
4. Caldenhoven E, Buitenhuis M, van Dijk TB, Raaijmakers JA, Lammers JW, Koenderman L, de Groot RP. 1999. Lineagespecific activation of STAT3 by interferon-gamma in human neutrophils. J Leukoc Biol 65(3):391-396.
5. Chaouat G, Assal Meliani A, Martal J, Raghupathy R, Elliott JF, Mosmann T, Wegmann TG. 1995. IL-10 prevents naturally occurring fetal loss in the CBA x DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau. J Immunol 154(9):4261-4268.
6. Chon TW, Bixler S. 2010. Interferon-tau: Current applications and potential in antiviral therapy. J Interferon Cytokine Res 30(7):477-485.
7. Darnell JE, Jr., Kerr IM, Stark GR. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264(5164):1415-1421.
8. Davidson JA, Betts JG, Tiemann U, Kamwanja LA, Monterroso VH, Hansen PJ. 1994. Effects of interferon-tau and interferonalpha on proliferation of bovine endometrial cells. Biol Reprod 51(4):700-705.
9. Desai N, Scarrow M, Lawson J, Kinzer D, Goldfarb J. 1999. Evaluation of the effect of interleukin-6 and human extracellullar matrix on embryonic development. Hum Reprod 14(6):1588-1592.
10. Dubinsky V, Junovich G, Gentile T, Gutierrez G. 2008. IL-6 as a regulatory factor of the humoral response during pregnancy. Am J Reprod Immunol 60(3):197-203.
11. Falkowska-Podstawka M, Bobowiec R, Rzeski W. 2006. The effect of interferon-tau and ovarian steroids on the proliferation of bovine endometrial cells in vitro. Pol J Vet Sci 9(4):239-246.
12. Fukai T, Ushio-Fukai M. 2011. Superoxide dismutases: Role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 15(6):1583-1606.
13. Gierek D, Baczynska D, Ugorski M, Bazer F, Kurpisz M, Bednarski T, Gorczykowski M, Chelmonska-Soyta A. 2006. Differential effect of IFN-tau on proliferation and distribution of lymphocyte subsets in one-way mixed lymphocyte reaction in cows and heifers. J Reprod Immunol 71(2):126-131.
14. Gil MP, Bohn E, O'Guin AK, Ramana CV, Levine B, Stark GR, Virgin HW, Schreiber RD. 2001. Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci USA 98(12):6680-6685.
15. Gough DJ, Messina NL, Clarke CJ, Johnstone RW, Levy DE. 2012. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36(2):166-174.
16. Gude NM, Roberts CT, Kalionis B, King RG. 2004. Growth and function of the normal human placenta. Thromb Res 114(5-6): 397-407.
17. Gutierrez G, Sarto A, Berod L, Canellada A, Gentile T, Pasqualini S, Margni RA. 2004. Regulation of interleukin-6 fetoplacental levels could be involved in the protective effect of low-molecular weight heparin treatment on murine spontaneous abortion. Am J Reprod Immunol 51(2):160-165.
18. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, Gazit R, Yutkin V, Benharroch D, Porgador A, Keshet E, Yagel S, Mandelboim O. 2006. Decidual NK cells regulate key developmental processes at the human fetalmaternal interface. Nat Med 12(9):1065-1074.
19. Hara K, Shirasuna K, Usui F, Karasawa T, Mizushina Y, Kimura H, Kawashima A, Ohkuchi A, Matsuyama S, Kimura K, Takahashi M. 2014. Interferon-tau attenuates uptake of nanoparticles and secretion of interleukin-1beta in macrophages. PLoS One 9(12):e113974.
20. Hirota Y, Osuga Y, Hasegawa A, Kodama A, Tajima T, Hamasaki K, Koga K, Yoshino O, Hirata T, Harada M, Takemura Y, Yano T, Tsutsumi O, Taketani Y. 2009. Interleukin (IL)-1beta stimulates migration and survival of first-trimester villous cytotrophoblast cells through endometrial epithelial cell-derived IL-8. Endocrinology 150(1):350-356.
21. Holmberg JC, Haddad S, Wunsche V, Yang Y, Aldo PB, Gnainsky Y, Granot I, Dekel N, Mor G. 2012. An in vitro model for the study of human implantation. Am J Reprod Immunol 67(2):169-178.
22. Imakawa K, Anthony RV, Kazemi M, Marotti KR, Polites HG, Roberts RM. 1987. Interferon-like sequence of ovine trophoblast protein secreted by embryonic trophectoderm. Nature 330(6146):377-379.
23. Imakawa K, Imai M, Sakai A, Suzuki M, Nagaoka K, Sakai S, Lee SR, Chang KT, Echternkamp SE, Christenson RK. 2006. Regulation of conceptus adhesion by endometrial CXC chemokines during the implantation period in sheep. Mol Reprod Dev 73(7):850-858.
24. Inoue M, Shinohara ML. 2013. The role of interferon-beta in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis-in the perspective of inflammasomes. Immunology 139(1):11-18.
25. Jovanovic M, Stefanoska I, Radojcic L, Vicovac L. 2010. Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta1. Reproduction 139(4):789-798.
26. Jung JE, Kim GS, Narasimhan P, Song YS, Chan PH. 2009. Regulation of Mn-superoxide dismutase activity and neuroprotection by STAT3 in mice after cerebral ischemia. J Neurosci 29(21):7003-7014.
27. Li A, Varney ML, Valasek J, Godfrey M, Dave BJ, Singh RK. 2005. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 8(1):63-71.
28. Liu J, Zhao S, Tang J, Li Z, Zhong T, Liu Y, Chen D, Zhao M, Li Y, Gong X, Deng P, Wang JH, Jiang Y. 2009. Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB. FEBS J 276(16): 4598-4606.
29. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402-408.
30. Nagaoka K, Nojima H, Watanabe F, Chang KT, Christenson RK, Sakai S, Imakawa K. 2003a. Regulation of blastocyst migration, apposition, and initial adhesion by a chemokine, interferon gamma-inducible protein 10 kDa (IP-10), during early gestation. J Biol Chem 278(31):29048-29056.
31. Nagaoka K, Sakai A, Nojima H, Suda Y, Yokomizo Y, Imakawa K, Sakai S, Christenson RK. 2003b. A chemokine, interferon (IFN)-gamma-inducible protein 10 kDa, is stimulated by IFN-tau and recruits immune cells in the ovine endometrium. Biol Reprod 68(4):1413-1421.
32. Nakajima A, Sokawa Y. 2002. Induction of blood 2', 5'-oligoadenylate synthetase activity in mice by gastric administration of ovine IFN-tau. J Interferon Cytokine Res 22(3): 397-402.
33. Nitta A, Shirasuna K, Haneda S, Matsui M, Shimizu T, Matsuyama S, Kimura K, Bollwein H, Miyamoto A. 2011. Possible involvement of IFNT in lymphangiogenesis in the corpus luteum during the maternal recognition period in the cow. Reproduction 142(6):879-892.
34. Orshal JM, Khalil RA. 2004. Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats. Am J Physiol Regul Integr Comp Physiol 286(6):R1013-R1023.
35. Padilla-Quirarte HO, Trejo-Moreno C, Fierros-Zarate G, Castaneda JC, Palma-Irizarry M, Hernandez-Marquez E, Burguete-Garcia AI, Peralta-Zaragoza O, Madrid-Marina V, Torres-Poveda K, Bermudez-Morales VH. 2016. Interferon-Tau has Antiproliferative effects, represses the expression of E6 and E7 oncogenes, induces apoptosis in cell lines transformed with HPV16 and inhibits tumor growth in vivo. J Cancer 7(15):2231-2240.
36. Pijnenborg R, Bland JM, Robertson WB, Brosens I. 1983. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 4(4):397-413.
37. Prins JR, Faas MM, Melgert BN, Huitema S, Timmer A, Hylkema MN, Erwich JJ. 2012a. Altered expression of immune-associated genes in first-trimester human decidua of pregnancies later complicated with hypertension or foetal growth restriction. Placenta 33(5):453-455.
38. Prins JR, Gomez-Lopez N, Robertson SA. 2012b. Interleukin-6 in pregnancy and gestational disorders. J Reprod Immunol 95(1-2):1-14.
39. Ren W, Chen S, Zhang L, Liu G, Hussain T, Hao X, Yin J, Duan J, Tan B, Wu G, Bazer FW, Yin Y. 2016. Interferon Tau affects mouse intestinal microbiota and expression of IL-17. Mediators Inflamm 2016:2839232.
40. Robertson SA, Christiaens I, Dorian CL, Zaragoza DB, Care AS, Banks AM, Olson DM. 2010. Interleukin-6 is an essential determinant of on-time parturition in the mouse. Endocrinology 151(8):3996-4006.
41. Robker RL, Watson LN, Robertson SA, Dunning KR, McLaughlin EA, Russell DL. 2014. Identification of sites of STAT3 action in the female reproductive tract through conditional gene deletion. PLoS One 9(7):e101182.
42. Rogez C, Martin M, Dereuddre-Bosquet N, Martal J, Dormont D, Clayette P. 2003. Anti-human immunodeficiency virus activity of tau interferon in human macrophages: Involvement of cellular factors and beta-chemokines. J Virol 77(23): 12914-12920.
43. Rogez-Kreuz C, Maneglier B, Martin M, Dereuddre-Bosquet N, Martal J, Dormont D, Clayette P. 2005. Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-tau in human macrophages. Int Immunol 17(8):1047-1057.
44. Saito S. 2001. Cytokine cross-talk between mother and the embryo/placenta. J Reprod Immunol 52(1-2):15-33.
45. Sakamoto E, Hato F, Kato T, Sakamoto C, Akahori M, Hino M, Kitagawa S. 2005. Type I and type II interferons delay human neutrophil apoptosis via activation of STAT3 and upregulation of cellular inhibitor of apoptosis 2. J Leukoc Biol 78(1):301-309.
46. Sharma S. 2014. Natural killer cells and regulatory T cells in early pregnancy loss. Int J Dev Biol 58(2-4):219-229.
47. Shimoya K, Matsuzaki N, Taniguchi T, Kameda T, Koyama M, Neki R, Saji F, Tanizawa O. 1992. Human placenta constitutively produces interleukin-8 during pregnancy and enhances its production in intrauterine infection. Biol Reprod 47(2):220-226.
48. Shirasuna K, Matsumoto H, Matsuyama S, Kimura K, Bollwein H, Miyamoto A. 2015. Possible role of interferon tau on the bovine corpus luteum and neutrophils during the early pregnancy. Reproduction 150(3):217-225.
49. Shirasuna K, Seno K, Ohtsu A, Shiratsuki S, Ohkuchi A, Suzuki H, Matsubara S, Nagayama S, Iwata H, Kuwayama T. 2016a. AGEs and HMGB1 increase inflammatory cytokine production from human placental cells, resulting in an enhancement of monocyte migration. Am J Reprod Immunol 75(5):557-568.
50. Shirasuna K, Takano H, Seno K, Ohtsu A, Karasawa T, Takahashi M, Ohkuchi A, Suzuki H, Matsubara S, Iwata H, Kuwayama T. 2016b. Palmitic acid induces interleukin-1beta secretion via NLRP3 inflammasomes and inflammatory responses through ROS production in human placental cells. J Reprod Immunol 116:104-112.
51. Soos JM, Stuve O, Youssef S, Bravo M, Johnson HM, Weiner HL, Zamvil SS. 2002. Cutting edge: Oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate. J Immunol 169(5):2231-2235.
52. Soos JM, Subramaniam PS, Hobeika AC, Schiffenbauer J, Johnson HM. 1995. The IFN pregnancy recognition hormone IFN-tau blocks both development and superantigen re-A ctivation of experimental allergic encephalomyelitis without associated toxicity. J Immunol 155(5):2747-2753.
53. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu Rev Biochem 67:227-264.
54. Stewart MD, Johnson GA, Vyhlidal CA, Burghardt RC, Safe SH, Yu-Lee LY, Bazer FW, Spencer TE. 2001. Interferon-tau activates multiple signal transducer and activator of transcription proteins and has complex effects on interferonresponsive gene transcription in ovine endometrial epithelial cells. Endocrinology 142(1):98-107.
55. Straszewski-Chavez SL, Abrahams VM, Alvero AB, Aldo PB, Ma Y, Guller S, Romero R, Mor G. 2009. The isolation and characterization of a novel telomerase immortalized first trimester trophoblast cell line, Swan 71. Placenta 30(11):939-948.
56. Vitorino Carvalho A, Eozenou C, Healey GD, Forde N, Reinaud P, Chebrout M, Gall L, Rodde N, Padilla AL, Delville CG, Leveugle M, Richard C, Sheldon IM, Lonergan P, Jolivet G, Sandra O. 2016. Analysis of STAT1 expression and biological activity reveals interferon-tau-dependent STAT1-regulated SOCS genes in the bovine endometrium. Reprod Fertil Dev 28(4):459-474.
57. Woldman I, Varinou L, Ramsauer K, Rapp B, Decker T. 2001. The Stat1 binding motif of the interferon-gamma receptor is sufficient to mediate Stat5 activation and its repression by SOCS3. J Biol Chem 276(49):45722-45728.
58. Yang CH, Murti A, Pfeffer SR, Kim JG, Donner DB, Pfeffer LM. 2001. Interferon alpha/beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt. J Biol Chem 276(17):13756-13761.
59. Ying W, Kanameni S, Chang CA, Nair V, Safe S, Bazer FW, Zhou B. 2014. Interferon tau alleviates obesity-induced adipose tissue inflammation and insulin resistance by regulating macrophage polarization. PLoS One 9(6):e98835.
60. Zenclussen AC, Hammerling GJ. 2015. Cellular regulation of the uterine microenvironment that enables embryo implantation. Front Immunol 6:321.